本页面由Tiger Trade Technology Pte. Ltd.提供服务

Krystal Biotech Inc.

321.16
-10.9100-3.29%
盘后:321.160.00000.00%16:00 EDT
成交量:28.13万
成交额:9,089.78万
市值:95.06亿
市盈率:40.32
高:331.93
开:331.48
低:320.95
收:332.07
52周最高:382.54
52周最低:181.44
股本:2,959.88万
流通股本:2,353.93万
量比:1.05
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):7.97
每股收益(LYR):6.84
净资产收益率:20.12%
总资产收益率:9.37%
市净率:6.99
市盈率(LYR):46.95

数据加载中...

2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/21

重要事件披露

Form 8-K - Current report
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/04

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities